EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Graph-based drug–target interaction modeling: from representation learning to output-driven drug discovery

Thanh Nguyen iD, Hien Minh To, Duy Anh Nguyen, Duy Trieu, Giang Nguyen

Briefings in Bioinformatics · 03.07.2026 · 27 (4)

DOI: 10.1093/bib/bbag392 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 18.07.2026. Verfasst von Thanh Nguyen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nanyang Biologics, 04-07 456 Alexandra Road, 119962, Singapore. Hauptthemen laut MEDLINE: Drug Discovery, Deep Learning, Proteins. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nanyang Biologics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graph-based deep learning has emerged as a powerful framework for modeling drug–target interactions (DTIs), enabling the integration of molecular, structural, and systems-level information within a unified representation. In this review, we survey graph-based DTI models across biomedical network-, sequence/hybrid-, and structure-based paradigms, which form a continuum from large-scale association inference to structure-resolved interaction modeling with increasing mechanistic specificity. Beyond architectural advances, we introduce an output-driven perspective in which models are evaluated according to how well their predictions align with the informational and decision-making requirements of different stages of the drug discovery pipeline. Within this framework, attention mechanisms and semi-supervised learning are discussed as key developments that enhance feature prioritization and data efficiency in data-limited settings. We further examine how model outputs support applications ranging from target identification and drug repurposing to structure-guided lead optimization. Finally, we analyze key benchmarking challenges, including data leakage, sequence redundancy, and structural bias, and discuss emerging directions such as multimodal integration and the use of predicted protein structures. Together, this review provides a unified perspective on the design, evaluation, and translational application of graph-based DTI models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryDeep LearningProteinsHumansRepresentation Machine LearningGraph Neural Networks

Stichwörter der Autor:innen

deep learningdrug discoverydrug–target interactiongraph neural networksmolecular representationmultimodal learning

Substanzen

Proteins

Autor:innen und Institutionen

  • Nanyang Biologics, 04-07 456 Alexandra Road, 119962, Singapore.

ORCID-Profile: Thanh Nguyen

Förderung

  • Nanyang Biologics

Zitieren

APA

Nguyen, T., To, H. M., Nguyen, D. A., Trieu, D., & Nguyen, G. (2026). Graph-based drug–target interaction modeling: from representation learning to output-driven drug discovery. Briefings in Bioinformatics, 27(4). https://doi.org/10.1093/bib/bbag392

Vancouver

Nguyen T, To HM, Nguyen DA, Trieu D, Nguyen G. Graph-based drug–target interaction modeling: from representation learning to output-driven drug discovery. Briefings in Bioinformatics. 2026;27(4). doi:10.1093/bib/bbag392

BibTeX
@article{Nguyen2026,
  author = {Nguyen, Thanh and To, Hien Minh and Nguyen, Duy Anh and Trieu, Duy and Nguyen, Giang},
  title = {Graph-based drug–target interaction modeling: from representation learning to output-driven drug discovery},
  journal = {Briefings in Bioinformatics},
  year = {2026},
  volume = {27},
  number = {4},
  doi = {10.1093/bib/bbag392}
}
Kostenlos starten →